Ocular Therapeutix, Inc. Appoints Two New Board Members
Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and
Pioneering Medical Innovations
Pioneering Medical Innovations
Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and
I-Therapeutix, Inc. announced today that it has changed its corporate name to Ocular Therapeutix, Inc. Amar Sawhney, President and CEO-stated
I-Therapeutix announced today that it has closed a $15million dollar Series C financing. The round was led by Polaris Venture
I-Therapeutix, Inc. announced today that Mr. Richard Packard and Dr. Daniel Calladine from the Prince Charles Eye Unit, King Edward